Welcome to our dedicated page for HMI news (Ticker: HMI), a resource for investors and traders seeking the latest updates and insights on HMI stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect HMI's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of HMI's position in the market.
Huami Corp. (NYSE: HMI) has partnered with Promaxo, Inc. to explore technology, commercialization, and market development opportunities. This collaboration focuses on artificial intelligence and product integration, with Huami taking a role in the global commercialization of Promaxo's innovative MRI technology, aimed primarily at urology applications. Promaxo is expected to leverage Huami's wearable technology to enhance patient health outcomes. Additionally, Huami is considering investing in Promaxo as part of its strategy to expand its industrial healthcare business.
Huami Corp. (NYSE: HMI) has appointed Mr. Bing Xie, a former Texas Instruments executive, as an independent director on its board. Mr. Xie brings over 21 years of experience from Texas Instruments, where he led global sales and served as president of Greater China. His expertise will contribute to Huami's strategy in the smart IoT sector and enhance health and medical initiatives. The board includes members with strong backgrounds in technology and finance, reinforcing Huami's commitment to innovation in smart health devices.
Huami Corporation (HMI) reported Q3 2020 revenue of RMB2.2 billion (US$329.2 million), a 20% increase year-over-year, driven by strong sales of Xiaomi's Mi Band 5 and other self-branded products. The GAAP diluted net income per share was RMB0.31 (US$0.05), down from RMB0.79 (US$0.11) in Q3 2019. Gross margin decreased to 20.6% from 25.2% due to a shift in product mix. Despite strong market conditions, the company anticipates challenges ahead due to pandemic-related delays and forecasts Q4 2020 revenue between RMB1.95 billion and RMB2.15 billion.
Huami Corp. (NYSE: HMI) has appointed Mr. Bing Xie, former Texas Instruments executive, as an independent director on its board as of November 22, 2020. Mr. Xie will contribute his extensive experience in global sales and applications to various board committees, including Audit and Corporate Governance. Huami aims to leverage his expertise to enhance strategies in the smart IoT and health sectors. The company, known for its health technology, shipped 37 million smart devices in 2019, capturing 23% of global category shipments.
Huami Corporation (NYSE:HMI) has announced that it will release its third quarter 2020 unaudited financial results on November 23, 2020, before the market opens. A conference call will follow at 7:30 a.m. EST on the same day. Interested parties can access the call via multiple toll-free numbers. The company emphasizes its technology-driven approach in the healthcare sector, reporting 42.3 million smart wearable devices shipped in 2019, capturing 26% of global shipments.
Huami Corporation (NYSE: HMI) announced a three-year extension of its strategic cooperation agreement with Xiaomi Corporation, maintaining its status as a preferred partner for developing Xiaomi's wearable products. The agreement also includes collaboration on AI-chips and algorithms for wearable devices. Huami's mission focuses on connecting health with technology, having shipped 42.3 million wearable devices in 2019, accounting for 26% of global shipments. The partnership aims to enhance Huami's capabilities in the wearable technology market.
Huami Corp. (NYSE: HMI) announced that David Cui has resigned as Chief Financial Officer, effective October 1, 2020, due to personal reasons. He will serve as a consultant during the transition period. Leon Cheng Deng has been appointed as the new CFO, bringing extensive experience from Royal Philips, where he was Global Head of Finance. The company's previous guidance shared on August 18 remains unchanged. Huami continues to focus on integrating technology with health and aims for further growth in the smart wearable device market.
Huami Corporation (NYSE: HMI) reported Q2 2020 revenues of RMB1.137 billion (US$161 million), a 9.5% increase year-over-year, with a notable 21.1% growth for the first half of 2020. However, GAAP diluted net income per share fell to RMB0.05 (US$0.01), down from RMB0.35 (US$0.05) in Q2 2019. The company experienced challenges due to the ongoing pandemic, impacting retail sales and product shipments. Despite this, Huami's product innovation, including the new Huangshan 2 chip and expansion of health data analytics, provides optimism for future growth.
Huami Corporation (NYSE: HMI) scheduled to announce its second quarter 2020 unaudited financial results on August 18, 2020, prior to market opening. A conference call will be held at 8:00 a.m. EST, allowing investors to discuss the results. The company, known for its smart wearable technology, shipped 42.3 million units in 2019 and boasts one of the largest biometric databases in its industry. Investors can access the call via toll-free numbers and a webcast, with a replay available post-call through August 25, 2020.
